Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Citi ups recommendation on GSK to 'buy'

(Sharecast News) - Citi has upgraded its rating on vaccines and drugs blue chip GSK to 'buy' while also boosting its earnings estimates. In a note published on Tuesday, the bank said it had based its decision on "compelling" data about Blenrep, GSK's novel treatment for multiple myeloma, as well as a range of other positive indicators.

It increased its earnings per share forecasts by 50%, reflecting the reinstatement of peak Blenrep revenues of around £2.5bn.

Citi said: "We have been teetering on the edge of upgrading GSK for several months.

"The compelling data with Blenrep in myeloma is the missing piece that pushes us over the line after the last seven years without a positive recommendation.

"Our upgrade is based not only on Blenrep's under-appreciated revenue potential but also the cumulative impact of the multiple incremental positives ranging from Zantac liability outlook, RSV/Shingrix, astute business development and [the] increasingly positive ViiV outlook post dolutegravir loss of exclusivity.

"GSK's recent commercial and pipeline wins put GSK in a stronger position to attract both external talent and pipeline assets."

As well as upgrading its rating from 'neutral', Citi upped its price target on the London-listed stock to 2,100p from 1,700p.

As at 0930 GMT, shares in GSK were up 1% at 1,636.4p.

GSK owns 78% of ViiV, an HIV specialist.

Share this article

Related Sharecast Articles

Tesla lays off 285 workers in Buffalo as job cuts continue
(Sharecast News) - Electric carmaker Tesla is to lay off 14% of its staff across two plants in New York, the company said in a regulatory filing on Thursday, following large-scale job cuts announced earlier in the week.
Blackstone first-quarter earnings narrowly beat forecasts
(Sharecast News) - Blackstone, the world's largest private equity firm, reported marginally better than expected first-quarter earnings on Thursday.
TSMC forecasts jump in second-quarter sales
(Sharecast News) - Taiwan Semiconductor Manufacturing Co said on Thursday it expects sales to jump in the second quarter on strong demand.
Empire Metals completes third phase of drilling at Pitfield
(Sharecast News) - Empire Metals announced the successful conclusion of its third phase of reverse circulation (RC) drilling at the Pitfield Project in Western Australia on Thursday.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.